NO20050132D0 - Vaksinesammensetning - Google Patents

Vaksinesammensetning

Info

Publication number
NO20050132D0
NO20050132D0 NO20050132A NO20050132A NO20050132D0 NO 20050132 D0 NO20050132 D0 NO 20050132D0 NO 20050132 A NO20050132 A NO 20050132A NO 20050132 A NO20050132 A NO 20050132A NO 20050132 D0 NO20050132 D0 NO 20050132D0
Authority
NO
Norway
Prior art keywords
vaccine composition
vaccine
composition
Prior art date
Application number
NO20050132A
Other languages
English (en)
Other versions
NO20050132L (no
Inventor
Pierre Michel Desmons
Jan Poolman
Ramon Faustino Barbera Morales
Francisco Jesus Doming Alvarez
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of NO20050132D0 publication Critical patent/NO20050132D0/no
Publication of NO20050132L publication Critical patent/NO20050132L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20050132A 2002-06-13 2005-01-11 Vaksinesammensetning som omfatter blanding av multivalente meningokokk yttermembran vesikler NO20050132L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0213622.4A GB0213622D0 (en) 2002-06-13 2002-06-13 Vaccine Corporation
PCT/EP2003/006094 WO2003105890A2 (en) 2002-06-13 2003-06-10 Vaccine composition

Publications (2)

Publication Number Publication Date
NO20050132D0 true NO20050132D0 (no) 2005-01-11
NO20050132L NO20050132L (no) 2005-02-11

Family

ID=9938532

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050132A NO20050132L (no) 2002-06-13 2005-01-11 Vaksinesammensetning som omfatter blanding av multivalente meningokokk yttermembran vesikler

Country Status (20)

Country Link
US (1) US20060110412A1 (no)
EP (1) EP1565211A2 (no)
JP (1) JP2005531614A (no)
KR (1) KR20050049431A (no)
CN (1) CN100387298C (no)
AR (1) AR040204A1 (no)
AU (1) AU2003236734A1 (no)
BR (1) BR0311777A (no)
CA (1) CA2488782A1 (no)
CL (1) CL2003001192A1 (no)
CU (1) CU23552A1 (no)
GB (1) GB0213622D0 (no)
MX (1) MXPA04012568A (no)
NO (1) NO20050132L (no)
NZ (1) NZ560766A (no)
PE (1) PE20040562A1 (no)
RU (1) RU2005100509A (no)
UY (1) UY27843A1 (no)
WO (1) WO2003105890A2 (no)
ZA (1) ZA200409547B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1322328B1 (en) 2000-07-27 2014-08-20 Children's Hospital & Research Center at Oakland Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
GB0419627D0 (en) * 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
JP4993750B2 (ja) 2005-01-27 2012-08-08 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド 髄膜炎菌に起因する疾患に対する広域防御のための、ｇｎａ１８７０を基にした小胞ワクチン
EP3020411A1 (en) * 2005-12-22 2016-05-18 GlaxoSmithKline Biologicals s.a. Vaccine
PL2066344T3 (pl) 2006-09-07 2011-10-31 Glaxosmithkline Biologicals Sa Skojarzona szczepionka zawierająca inaktywowany wirus polio
EP2200642B1 (en) 2007-10-19 2012-04-18 Novartis AG Meningococcal vaccine formulations
US20090124573A1 (en) 2007-11-09 2009-05-14 Sarkis Mazmanian Immunomodulating compounds and related compositions and methods
BRPI0907010A2 (pt) * 2008-02-01 2015-07-07 Sanofi Pasteur Ltd Análise para o diagnóstico de streptococcus pneumoniae
MY150481A (en) 2008-03-03 2014-01-30 Irm Llc Compounds and compositions as tlr activity modulators
EP2367568A2 (en) 2008-12-17 2011-09-28 Novartis AG Meningococcal vaccines including hemoglobin receptor
US9517263B2 (en) 2009-06-10 2016-12-13 Glaxosmithkline Biologicals Sa Benzonaphthyridine-containing vaccines
CA2772103A1 (en) 2009-08-27 2011-03-03 Novartis Ag Adjuvant comprising aluminium, oligonucleotide and polycation
ES2443952T3 (es) 2009-09-02 2014-02-21 Novartis Ag Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
TWI445708B (zh) 2009-09-02 2014-07-21 Irm Llc 作為ｔｌｒ活性調節劑之化合物及組合物
WO2011043538A2 (ko) * 2009-10-08 2011-04-14 주식회사이언메딕스 실내 공기유래 세포밖 소포체를 포함하는 조성물 및 이의 용도
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
SG181712A1 (en) 2009-12-15 2012-07-30 Novartis Ag Homogeneous suspension of immunopotentiating compounds and uses thereof
EP2515938A4 (en) * 2009-12-22 2013-08-28 Sanofi Pasteur Ltd IMMUNOGENIC COMPOSITIONS
CA2793510A1 (en) 2010-03-18 2012-02-16 Novartis Ag Adjuvanted vaccines for serogroup b meningococcus
CA2792938C (en) 2010-03-23 2018-07-31 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
ES2694100T3 (es) * 2010-04-07 2018-12-18 California Institute Of Technology Vehículo para distribuir un compuesto en una membrana mucosa y composiciones, procedimientos y sistemas relacionados
AU2011300418B2 (en) * 2010-09-10 2016-05-12 Glaxosmithkline Biologicals Sa Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom
US20150147356A1 (en) 2011-05-12 2015-05-28 Alan Kimura Antipyretics to enhance tolerability of vesicle-based vaccines
EP2731617A4 (en) 2011-07-12 2015-07-01 Brigham & Womens Hospital LIPID-CONTAINING PSA COMPOSITIONS, METHODS OF ISOLATION AND METHODS OF USING SAME
RU2014135522A (ru) 2012-02-02 2016-03-27 Новартис Аг Промоторы для увеличенной экспрессии белка у менингококка
JP2015517089A (ja) 2012-03-08 2015-06-18 ノバルティス アーゲー タンパク質ベースの髄膜炎菌ワクチンのためのインビトロ有効性アッセイ
US10376573B2 (en) 2012-06-14 2019-08-13 Glaxosmithkline Biologicals Sa Vaccines for serogroup X meningococcus
AU2013311702A1 (en) 2012-09-06 2015-02-19 Novartis Ag Combination vaccines with serogroup B meningococcus and D/T/P
US11331335B2 (en) 2015-06-10 2022-05-17 California Institute Of Technology Sepsis treatment and related compositions methods and systems
JP6918365B2 (ja) 2015-08-19 2021-08-11 プレジデント アンド フェローズ オブ ハーバード カレッジ 脂質化ｐｓａ組成物および方法
WO2018014012A1 (en) 2016-07-15 2018-01-18 President And Fellows Of Harvard College Glycolipid compositions and methods of use
US20180064801A1 (en) 2016-09-02 2018-03-08 Glaxosmithkline Biologicals Sa Vaccines for neisseria gonorrhoeae
MX2023004729A (es) * 2020-10-23 2023-06-29 Omvax Inc Composiciones y metodos de vacunacion contra neisseria gonorrhoeae.
GB202115077D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU748973B2 (en) * 1997-07-17 2002-06-13 Baxter Healthcare Sa Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
EP1322328B1 (en) * 2000-07-27 2014-08-20 Children's Hospital & Research Center at Oakland Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis

Also Published As

Publication number Publication date
MXPA04012568A (es) 2005-09-21
CA2488782A1 (en) 2003-12-24
NZ560766A (en) 2009-09-25
JP2005531614A (ja) 2005-10-20
GB0213622D0 (en) 2002-07-24
AR040204A1 (es) 2005-03-16
PE20040562A1 (es) 2004-10-19
BR0311777A (pt) 2005-03-29
KR20050049431A (ko) 2005-05-25
CN1668329A (zh) 2005-09-14
WO2003105890A2 (en) 2003-12-24
CN100387298C (zh) 2008-05-14
US20060110412A1 (en) 2006-05-25
RU2005100509A (ru) 2006-06-10
UY27843A1 (es) 2003-12-31
CU23552A1 (es) 2010-07-20
WO2003105890A3 (en) 2004-03-25
ZA200409547B (en) 2006-07-26
CL2003001192A1 (es) 2005-01-07
NO20050132L (no) 2005-02-11
AU2003236734A1 (en) 2003-12-31
EP1565211A2 (en) 2005-08-24

Similar Documents

Publication Publication Date Title
NO20050132D0 (no) Vaksinesammensetning
IS7806A (is) Ónæmisvaldandi samsetning
DK1390066T3 (da) Vaccinesammensætning
IS7547A (is) Ónæmisvaldandi samsetningar
IS7831A (is) Bóluefni
FR2862654B1 (fr) Composition amylacee filmogene
DK3536344T3 (da) Superfin formoterolformulering
IS8387A (is) Ónæmisvaldandi samsetningar
DE10393374D2 (de) Zusammensetzung
IS8309A (is) Lyfjablöndur
SE0500163L (sv) Sammansättning
DK1587478T3 (da) Farmaceutisk sammensætning
DK1561472T3 (da) Faststofsammensætning
DE60320902D1 (de) Zusammensetzungen mit ausgelöster Freisetzung
DE60327447D1 (de) Pflaster
DK1492934T3 (da) Dørenhed
IS2922B (is) Bóluefni
DE60328408D1 (de) Impfstoff
NO20051561D0 (no) Vaksine
DE60328488D1 (de) Ng
NO20044140D0 (no) New Composition
ATE365529T1 (de) Schweisshemmende zusammensetzungen
NO20044164L (no) Farmasoytiske sammensetninger
DE60320425D1 (de) Ostertagia-impfstoff
SE0202138D0 (sv) Novel Composition

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application